Zions (ZION) reported $879 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 3.3%. EPS of $1.74 for the same period compares to $1.58 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $879.16 million, representing a surprise of -0.02%. The company delivered an EPS surprise of +10.83%, with the consensus EPS estimate being $1.57.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Zions performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Efficiency Ratio: 62.2% versus the five-analyst average estimate of 62.7%. Net interest margin: 3.3% versus 3.4% estimated by five analysts on average. Average balance - Total interest-earning assets: $84.35 billion versus the four-analyst average estimate of $82.99 billion. Net charge-offs to average loans and leases: 0.1% compared to the 0.1% average estimate based on four analysts. Total nonaccrual Loan: $292 million versus $306.75 million estimated by three analysts on average. Total nonperforming assets: $298 million compared to the $317.58 million average estimate based on three analysts. Tier 1 risk-based capital ratio: 11.9% versus the two-analyst average estimate of 11.8%. Total risk-based capital ratio: 14% compared to the 14% average estimate based on two analysts. Tier 1 leverage ratio: 9.4% versus the two-analyst average estimate of 9.3%. Total Noninterest Income: $460 million versus the five-analyst average estimate of $189.81 million. Commercial account fees: $49 million compared to the $49.14 million average estimate based on four analysts. Other customer-related fees: $16 million compared to the $15.03 million average estimate based on four analysts.View all Key Company Metrics for Zions here>>>
Shares of Zions have returned +9.2% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
(We are reissuing this article to correct a mistake. The original article, issued on July 20, 2026, should no longer be relied upon.)
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Zions Bancorporation, N.A. (ZION): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).